XNYS 06 May, 2026 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Joseph C. Ventura | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 10,318 | 27,405 (0%) | 0% | 0 | Humana Common | |
| Michelle A. O’Hara | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 10,485 | 20,026 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 9,945 | 22,088 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 35,633 | 63,938 (0%) | 0% | 0 | Humana Common | |
| David E. Dintenfass | President, Enterprise Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 11,273 | 25,407 (0%) | 0% | 0 | Humana Common | |
| Japan A. Mehta | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 9,448 | 17,176 (0%) | 0% | 0 | Humana Common | |
| Aaron Martin | President, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 8,206 | 25,237 (0%) | 0% | 0 | Humana Common | |
| Robert S. Field | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 May 2026 | 852 | 852 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2026 | 887 | 12,544 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 175.44 per share. | 01 Apr 2026 | 401 | 12,143 (0%) | 0% | 175.4 | 70,351 | Humana Common |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2026 | 536 | 16,301 | - | - | Restricted Stock Units | |
| George Renaudin | President, Insurance | Other type of transaction at price $ 0.00 per share. | 31 Mar 2026 | 25 | 199 | - | - | Phantom Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 1,035 | 17,565 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.08 per share. | 24 Feb 2026 | 478 | 17,087 (0%) | 0% | 177.1 | 84,642 | Humana Common |
| George Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.07 per share. | 24 Feb 2026 | 419 | 16,075 (0%) | 0% | 177.1 | 74,194 | Humana Common |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2026 | 1,035 | 16,494 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Purchase of securities on an exchange or from another person at price $ 185.20 per share. | 23 Feb 2026 | 810 | 11,657 (0%) | 0% | 185.2 | 150,016 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Feb 2026 | 165 | 7,568 (0%) | 0% | 0 | Humana Common | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 177.07 per share. | 23 Feb 2026 | 84 | 7,484 (0%) | 0% | 177.1 | 14,874 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Feb 2026 | 5,669 | 7,403 (0%) | 0% | 0 | Humana Common | |
| David E. Dintenfass | President, Enterprise Growth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2026 | 3,858 | 15,316 (0%) | 0% | 0 | Humana Common | |
| David E. Dintenfass | President, Enterprise Growth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 189.65 per share. | 21 Feb 2026 | 1,182 | 14,134 (0%) | 0% | 189.7 | 224,172 | Humana Common |
| Japan A. Mehta | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 181.46 per share. | 13 Feb 2026 | 430 | 7,728 (0%) | 0% | 181.5 | 78,027 | Humana Common |
| Japan A. Mehta | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2026 | 1,682 | 8,158 (0%) | 0% | 0 | Humana Common | |
| Aaron Martin | President, Medicare Advantage | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2026 | 17,031 | 17,031 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2026 | 2,183 | 2,183 | - | - | Restricted Stock Units | |
| James A. Rechtin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2026 | 2,183 | 29,285 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 279.15 per share. | 08 Jan 2026 | 980 | 28,305 (0%) | 0% | 279.1 | 273,565 | Humana Common |
| Frank A. D’Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 766 | 26,826 | - | - | Restricted Stock Units | |
| Jorge S. Mesquita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 766 | 4,127 (0%) | 0% | 0 | Humana Common | |
| Michelle A. O’Hara | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.87 per share. | 01 Jan 2026 | 1,093 | 9,541 (0%) | 0% | 258.9 | 282,942 | Humana Common |
| Michelle A. O’Hara | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jan 2026 | 2,353 | 10,634 (0%) | 0% | 0 | Humana Common | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 10 | 10 | - | - | Restricted Stock Units | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 122 | 500 | - | - | Restricted Stock Units | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 1,549 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 611 | 3,364 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 357 | 15,765 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 24,800 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 49 | 124 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 3,627 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 29 | 46 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 1,207 (0%) | 0% | 0 | Humana Common | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 70 | 708 | - | - | Restricted Stock Units | |
| John W. Garratt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 16 | 18 | - | - | Restricted Stock Units | |
| John W. Garratt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 1,929 | - | - | Restricted Stock Units | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 28 | 53 | - | - | Restricted Stock Units | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 2,771 | - | - | Restricted Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 3,174 | - | - | Restricted Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 35 | 73 | - | - | Restricted Stock Units | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 766 | 3,174 | - | - | Restricted Stock Units | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2025 | 34 | 72 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.15 per share. | 15 Dec 2025 | 164 | 16,530 (0%) | 0% | 270.2 | 44,305 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 360 | 16,694 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 933 | 16,334 (0%) | 0% | 270.2 | 252,055 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 2,046 | 17,267 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 360 | 0 | - | - | Restricted Stock Units | |
| Michelle A. O’Hara | Chief Human Resources Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,401 | 11,266 (0%) | 0% | 0 | Humana Common | |
| Michelle A. O’Hara | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 632 | 10,634 (0%) | 0% | 270.2 | 170,738 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 115 | 1,787 (0%) | 0% | 0 | Humana Common | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.15 per share. | 15 Dec 2025 | 53 | 1,734 (0%) | 0% | 270.2 | 14,318 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 115 | 0 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.15 per share. | 15 Dec 2025 | 209 | 1,672 (0%) | 0% | 270.2 | 56,462 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 455 | 1,881 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 360 | 0 | - | - | Restricted Stock Units | |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 2,106 | 16,071 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 830 | 15,241 (0%) | 0% | 270.2 | 224,229 | Humana Common |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 360 | 15,601 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.15 per share. | 15 Dec 2025 | 142 | 15,459 (0%) | 0% | 270.2 | 38,362 | Humana Common |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 308 | 10,986 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 308 | 0 | - | - | Restricted Stock Units | |
| Sanjay K. Shetty | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 139 | 10,847 (0%) | 0% | 270.2 | 37,552 | Humana Common |
| Sanjay K. Shetty | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 888 | 10,678 (0%) | 0% | 270.2 | 239,898 | Humana Common |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,968 | 11,566 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 7,707 | 30,474 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 3,372 | 27,102 (0%) | 0% | 270.2 | 910,963 | Humana Common |
| David E. Dintenfass | President, Enterprise Growth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.15 per share. | 15 Dec 2025 | 918 | 15,316 (0%) | 0% | 270.2 | 248,002 | Humana Common |
| David E. Dintenfass | President, Enterprise Growth | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 2,032 | 16,234 (0%) | 0% | 0 | Humana Common | |
| Japan A. Mehta | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2025 | 1,194 | 8,628 (0%) | 0% | 0 | Humana Common | |
| Japan A. Mehta | Chief Information Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 270.16 per share. | 15 Dec 2025 | 470 | 8,158 (0%) | 0% | 270.2 | 126,973 | Humana Common |
| Gordon A. Smith | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2025 | 765 | 765 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 609 | 16,311 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2025 | 609 | 0 | - | - | Restricted Stock Units | |
| George Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 253.12 per share. | 01 Oct 2025 | 240 | 16,071 (0%) | 0% | 253.1 | 60,749 | Humana Common |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 124 | 378 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 364 | 15,408 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2025 | 69 | 638 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 211 | 0 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.41 per share. | 01 Aug 2025 | 97 | 1,881 (0%) | 0% | 248.4 | 24,096 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2025 | 211 | 1,978 (0%) | 0% | 0 | Humana Common | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 136 | 254 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 399 | 15,044 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 76 | 569 | - | - | Restricted Stock Units | |
| James A. Rechtin | President & CEO | Purchase of securities on an exchange or from another person at price $ 229.25 per share. | 14 May 2025 | 6,530 | 30,474 (0%) | 0% | 229.2 | 1,496,984 | Humana Common |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 118 | 118 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 345 | 14,645 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 66 | 493 | - | - | Restricted Stock Units | |
| George Renaudin | President, Insurance | Other type of transaction at price $ 0.00 per share. | 27 Mar 2025 | 5 | 170 | - | - | Phantom Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 876 | 1,767 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 19,037 | 23,944 (0%) | 0% | 0 | Humana Common | |
| Shetty Sanjay K. | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 4,205 | 11,566 (0%) | 0% | 0 | Humana Common | |
| Michelle A. O’Hara | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 4,205 | 11,266 (0%) | 0% | 0 | Humana Common | |
| Mehta A. Japan | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2025 | 3,582 | 8,628 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 1,970 | 14,352 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 3,270 | 16,717 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.57 per share. | 21 Feb 2025 | 905 | 13,447 (0%) | 0% | 258.6 | 234,010 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.57 per share. | 21 Feb 2025 | 1,065 | 12,829 (0%) | 0% | 258.6 | 275,382 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 2,308 | 13,894 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 4,438 | 17,267 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.58 per share. | 21 Feb 2025 | 300 | 11,186 (0%) | 0% | 258.6 | 77,573 | Humana Common |
| George Renaudin | President, Insurance | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 4,516 | 15,702 (0%) | 0% | 0 | Humana Common | |
| George Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2025 | 732 | 11,486 (0%) | 0% | 0 | Humana Common | |
| David E. Dintenfass | President, Enterprise Growth | Payment of exercise price or tax liability using portion of securities received from the company at price $ 258.58 per share. | 21 Feb 2025 | 1,175 | 11,874 (0%) | 0% | 258.6 | 303,826 | Humana Common |
| David E. Dintenfass | President, Enterprise Growth | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2025 | 4,360 | 16,234 (0%) | 0% | 0 | Humana Common | |
| Japan Mehta A. | Chief Information Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 5,046 | 5,046 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2025 | 2,182 | 5,885 (0%) | 0% | 0 | Humana Common | |
| James A. Rechtin | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 264.68 per share. | 08 Jan 2025 | 978 | 4,907 (0%) | 0% | 264.7 | 258,857 | Humana Common |
| James A. Rechtin | President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Jan 2025 | 2,182 | 4,366 | - | - | Restricted Stock Units | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 783 | - | - | Restricted Stock Units | |
| Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 26,060 | - | - | Restricted Stock Units | |
| Jorge S. Mesquita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 3,361 (0%) | 0% | 0 | Humana Common | |
| John W. Garratt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 783 | 1,163 | - | - | Restricted Stock Units | |
| Michelle A. O’Hara | Chief Human Resources Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jan 2025 | 7,061 | 7,061 (0%) | 0% | 0 | Humana Common | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 2,408 | - | - | Restricted Stock Units | |
| Brad D. Smith | Director | 31 Dec 2024 | 783 | 1,169 (0%) | 0% | 0 | Humana Common | ||
| Brad D. Smith | Director | 31 Dec 2024 | 231 | 771 | - | - | Restricted Stock Units | ||
| Brad D. Smith | Director | 31 Dec 2024 | 17 | 20 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 673 | 14,300 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 565 | 2,753 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 24,034 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 38 | 75 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 2,861 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 131 | 427 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 14 | 17 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 1,593 | - | - | Restricted Stock Units | |
| Timothy S. Huval | Chief Administrative Officer | 31 Dec 2024 | 1,070 | 7,111 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 31 Dec 2024 | 3,703 | 8,181 (0%) | 0% | 256.3 | 948,925 | Humana Common | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 17 | 25 | - | - | Restricted Stock Units | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 2,005 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 31 Dec 2024 | 1 | 332 | - | - | Phantom Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 23 | 38 | - | - | Restricted Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 783 | 2,408 | - | - | Restricted Stock Units | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 23 | 38 | - | - | Restricted Stock Units | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 343 | 343 | - | - | Restricted Stock Units | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 362 | 0 | - | - | Restricted Stock Units | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 247 | 11,500 (0%) | 0% | 271.7 | 67,104 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 362 | 11,862 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 165 | 11,697 (0%) | 0% | 271.7 | 44,826 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 343 | 12,040 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2024 | 156 | 11,884 (0%) | 0% | 271.7 | 42,381 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 152 | 14,015 (0%) | 0% | 271.7 | 41,295 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 335 | 14,167 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 160 | 13,832 (0%) | 0% | 271.7 | 43,468 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 353 | 13,992 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 221 | 13,639 (0%) | 0% | 271.7 | 60,040 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 335 | 335 | - | - | Restricted Stock Units | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2024 | 353 | 0 | - | - | Restricted Stock Units | ||
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 140 | 12,382 (0%) | 0% | 271.7 | 38,035 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 310 | 12,522 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 140 | 12,212 (0%) | 0% | 271.7 | 38,035 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 309 | 12,352 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 205 | 12,043 (0%) | 0% | 271.7 | 55,693 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 309 | 0 | - | - | Restricted Stock Units | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 310 | 311 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 164 | 11,586 (0%) | 0% | 271.7 | 44,555 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 362 | 0 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 359 | 360 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 359 | 11,750 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 165 | 11,391 (0%) | 0% | 271.7 | 44,826 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 362 | 11,556 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 259 | 11,194 (0%) | 0% | 271.7 | 70,364 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 268 | 20,165 (0%) | 0% | 271.7 | 72,809 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 588 | 20,433 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 234 | 19,845 (0%) | 0% | 271.7 | 63,572 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 512 | 20,079 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 393 | 19,567 (0%) | 0% | 271.7 | 106,768 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 588 | 588 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 512 | 0 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 49 | 811 (0%) | 0% | 271.7 | 13,312 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 34 | 891 (0%) | 0% | 271.7 | 9,237 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 114 | 115 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 114 | 925 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 359 | 10,856 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 359 | 360 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 230 | 0 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 102 | 10,754 (0%) | 0% | 271.7 | 27,711 | Humana Common |
| George II Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 57 | 10,497 (0%) | 0% | 271.7 | 15,485 | Humana Common |
| George II Renaudin | President, Insurance | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 230 | 10,554 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Insurance | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 237 | 10,324 (0%) | 0% | 271.7 | 64,387 | Humana Common |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 308 | 308 | - | - | Restricted Stock Units | |
| Sanjay K. Shetty | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.67 per share. | 15 Dec 2024 | 171 | 7,146 (0%) | 0% | 271.7 | 46,456 | Humana Common |
| Sanjay K. Shetty | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2024 | 308 | 7,454 (0%) | 0% | 0 | Humana Common | |
| Sanjay K. Shetty | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 93 | 7,361 (0%) | 0% | 271.7 | 25,266 | Humana Common |
| James A. Rechtin | President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 271.68 per share. | 15 Dec 2024 | 392 | 3,693 (0%) | 0% | 271.7 | 106,497 | Humana Common |
| David Dintenfass | President, Enterprise Growth | 15 Dec 2024 | 261 | 13,049 (0%) | 0% | 271.7 | 70,907 | Humana Common | |
| Gordon A. Smith | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2024 | 765 | 765 (0%) | 0% | 0 | Humana Common | |
| Brad D. Smith | Director | 30 Sep 2024 | 102 | 540 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 295 | 13,627 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 57 | 296 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,241 | 10,864 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 352.14 per share. | 01 Sep 2024 | 303 | 10,561 (0%) | 0% | 352.1 | 106,698 | Humana Common |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2024 | 1,241 | 0 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 311 | 20,102 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 311 | 0 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 357.32 per share. | 01 Aug 2024 | 142 | 19,960 (0%) | 0% | 357.3 | 50,740 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 210 | 923 (0%) | 0% | 0 | Humana Common | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 357.32 per share. | 01 Aug 2024 | 63 | 860 (0%) | 0% | 357.3 | 22,511 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 210 | 211 | - | - | Restricted Stock Units | |
| Brad D. Smith | Director | 28 Jun 2024 | 84 | 438 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 246 | 13,332 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jun 2024 | 47 | 239 | - | - | Restricted Stock Units | |
| Brad D. Smith | Director | 28 Mar 2024 | 92 | 354 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 270 | 13,086 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Mar 2024 | 51 | 192 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Other type of transaction at price $ 0.00 per share. | 28 Mar 2024 | 8 | 162 | - | - | Phantom Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.10 per share. | 21 Feb 2024 | 278 | 2,373 (0%) | 0% | 366.1 | 101,777 | Humana Common |
| William Kevin Fleming | Chief Corporate Aff. Officer | 21 Feb 2024 | 1,396 | 11,723 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 21 Feb 2024 | 3,770 | 13,698 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 21 Feb 2024 | 5,652 | 5,652 | - | - | Options | ||
| Bruce D. Broussard | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.11 per share. | 21 Feb 2024 | 8,473 | 88,344 (0%) | 0% | 366.1 | 3,102,008 | Humana Common |
| David Dintenfass | President, Enterprise Growth | 21 Feb 2024 | 51,389 | 51,389 | - | - | Options | ||
| Diamond Susan M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 13,480 | 19,791 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 6,572 | 6,572 | - | - | Options | |
| A. James Rechtin | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 4,085 | 4,085 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 22,572 | 96,817 (0%) | 0% | 0 | Humana Common | |
| S. Huval Timothy | Chief Administrative Officer | 21 Feb 2024 | 1,284 | 7,390 (0%) | 0% | 366.1 | 470,079 | Humana Common | |
| Kevin Fleming William | Chief Corporate Aff. Officer | 21 Feb 2024 | 1,226 | 10,327 (0%) | 0% | 366.1 | 448,845 | Humana Common | |
| Sanjay Shetty K. | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 6,572 | 6,572 | - | - | Options | |
| Dintenfass David | President, Enterprise Growth | 21 Feb 2024 | 13,310 | 13,310 (0%) | 0% | 0 | Humana Common | ||
| Fleming William Kevin | Chief Corporate Aff. Officer | 21 Feb 2024 | 3,566 | 11,553 (0%) | 0% | 0 | Humana Common | ||
| Kevin William Fleming | Chief Corporate Aff. Officer | 21 Feb 2024 | 5,389 | 5,389 | - | - | Options | ||
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 5,257 | 5,257 | - | - | Options | |
| Susan Diamond M. | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.10 per share. | 21 Feb 2024 | 1,125 | 6,311 (0%) | 0% | 366.1 | 411,868 | Humana Common |
| S. Timothy Huval | Chief Administrative Officer | 21 Feb 2024 | 6,309 | 6,309 | - | - | Options | ||
| George II Renaudin | President, Medicare & Medicaid | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 6,966 | 6,966 | - | - | Options | |
| Sanjay Shetty K. | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 7,148 | 7,317 (0%) | 0% | 0 | Humana Common | |
| Deshpande Samir | Chief Information Officer | 21 Feb 2024 | 1,464 | 13,860 (0%) | 0% | 0 | Humana Common | ||
| Deshpande Samir | Chief Information Officer | 21 Feb 2024 | 1,302 | 12,396 (0%) | 0% | 366.1 | 476,669 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 3,010 | 11,845 (0%) | 0% | 0 | Humana Common | |
| Broussard D. Bruce | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 21,786 | 110,130 (0%) | 0% | 0 | Humana Common | |
| A. James Rechtin | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 15,772 | 15,772 | - | - | Options | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.11 per share. | 21 Feb 2024 | 959 | 10,886 (0%) | 0% | 366.1 | 351,095 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 1,362 | 12,248 (0%) | 0% | 0 | Humana Common | |
| Diamond Susan M. | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 9,989 | 9,989 | - | - | Options | |
| Timothy Huval S. | Chief Administrative Officer | 21 Feb 2024 | 3,712 | 8,674 (0%) | 0% | 0 | Humana Common | ||
| C. Joseph Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 3,411 | 8,181 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 1,104 | 2,651 (0%) | 0% | 0 | Humana Common | |
| Ventura C. Joseph | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 366.10 per share. | 21 Feb 2024 | 1,153 | 7,028 (0%) | 0% | 366.1 | 422,119 | Humana Common |
| C. Ventura Joseph | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 4,425 | 11,453 (0%) | 0% | 0 | Humana Common | |
| Huval S. Timothy | Chief Administrative Officer | 21 Feb 2024 | 4,357 | 11,747 (0%) | 0% | 0 | Humana Common | ||
| George II Renaudin | President, Medicare & Medicaid | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 7,250 | 9,623 (0%) | 0% | 0 | Humana Common | |
| W. Felter John-Paul | SVP, Chief Accting Off & Cont. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2024 | 490 | 713 (0%) | 0% | 0 | Humana Common | |
| Susan Diamond M. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 3,356 | 7,436 (0%) | 0% | 0 | Humana Common | |
| Jorge S. Mesquita | Director | Purchase of securities on an exchange or from another person at price $ 367.09 per share. | 20 Feb 2024 | 545 | 2,578 (0%) | 0% | 367.1 | 200,066 | Humana Common |
| James A. Rechtin | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 6,548 | 6,548 | - | - | Restricted Stock Units | |
| Rechtin James A. | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2024 | 29,230 | 29,230 | - | - | Options | |
| S. Mesquita Jorge | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 430 | 2,033 (0%) | 0% | 0 | Humana Common | |
| D'Amelio Frank A. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 430 | 430 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| W. Katz Karen | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| A.I. Frederick Wayne | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| David Feinberg T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 40 | 141 | - | - | Restricted Stock Units | |
| Klevorn Marcy S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 6 | 8 | - | - | Restricted Stock Units | |
| D. Brad Smith | Director | 31 Dec 2023 | 71 | 262 | - | - | Restricted Stock Units | ||
| J. Hilzinger Kurt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 304 | 2,188 | - | - | Restricted Stock Units | |
| W. Karen Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 17 | 37 | - | - | Restricted Stock Units | |
| W. Garratt John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 1,685 (0%) | 0% | 0 | Humana Common | |
| T. Feinberg David | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 3 | 3 | - | - | Restricted Stock Units | |
| Klevorn Marcy S. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| Bono C. Raquel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 9 | 15 | - | - | Restricted Stock Units | |
| A.I. Wayne Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 9 | 15 | - | - | Restricted Stock Units | |
| Kurt Hilzinger J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 211 | 12,816 | - | - | Restricted Stock Units | |
| Brad Smith D. | Director | 31 Dec 2023 | 3 | 3 | - | - | Restricted Stock Units | ||
| Mcdonald J. William | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 257 | 2,123 | - | - | Restricted Stock Units | |
| Brad Smith D. | Director | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | ||
| C. Bono Raquel | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| David Feinberg T. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| Garratt W. John | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 2 | 2 | - | - | Restricted Stock Units | |
| William Mcdonald J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 430 | 430 | - | - | Restricted Stock Units | |
| Shetty K Sanjay | President, CenterWell | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 139 | 169 (0%) | 0% | 463.6 | 64,438 | Humana Common |
| Samir Deshpande | Chief Information Officer | 15 Dec 2023 | 353 | 9,905 (0%) | 0% | 0 | Humana Common | ||
| William Fleming Kevin | Chief Corporate Aff. Officer | 15 Dec 2023 | 390 | 7,808 (0%) | 0% | 0 | Humana Common | ||
| Shetty K Sanjay | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 308 | 308 (0%) | 0% | 0 | Humana Common | |
| Fleming Kevin William | Chief Corporate Aff. Officer | 15 Dec 2023 | 345 | 7,974 (0%) | 0% | 0 | Humana Common | ||
| M. Susan Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 512 | 512 | - | - | Restricted Stock Units | |
| William Fleming Kevin | Chief Corporate Aff. Officer | 15 Dec 2023 | 319 | 639 | - | - | Restricted Stock Units | ||
| Ventura C. Joseph | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 174 | 4,386 (0%) | 0% | 463.6 | 80,663 | Humana Common |
| John-Paul Felter W. | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 114 | 229 | - | - | Restricted Stock Units | |
| William Kevin Fleming | Chief Corporate Aff. Officer | 15 Dec 2023 | 179 | 7,629 (0%) | 0% | 463.6 | 82,981 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 367 | 0 | - | - | Restricted Stock Units | |
| Renaudin George II | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 95 | 1,192 (0%) | 0% | 463.6 | 44,040 | Humana Common |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 359 | 719 | - | - | Restricted Stock Units | |
| Diamond M. Susan | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 239 | 3,766 (0%) | 0% | 463.6 | 110,796 | Humana Common |
| D. Bruce Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,465 | 72,505 (0%) | 0% | 0 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2023 | 362 | 362 | - | - | Restricted Stock Units | ||
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 367 | 3,664 (0%) | 0% | 0 | Humana Common | |
| Timothy Huval S. | Chief Administrative Officer | 15 Dec 2023 | 189 | 4,585 (0%) | 0% | 463.6 | 87,617 | Humana Common | |
| Huval S. Timothy | Chief Administrative Officer | 15 Dec 2023 | 343 | 686 | - | - | Restricted Stock Units | ||
| Renaudin George II | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 91 | 1,330 (0%) | 0% | 463.6 | 42,186 | Humana Common |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 241 | 0 | - | - | Restricted Stock Units | |
| William Fleming Kevin | Chief Corporate Aff. Officer | 15 Dec 2023 | 319 | 8,134 (0%) | 0% | 0 | Humana Common | ||
| Deshpande Samir | Chief Information Officer | 15 Dec 2023 | 160 | 9,745 (0%) | 0% | 463.6 | 74,173 | Humana Common | |
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 140 | 8,665 (0%) | 0% | 463.6 | 64,901 | Humana Common |
| Bruce Broussard D. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 970 | 71,535 (0%) | 0% | 463.6 | 449,673 | Humana Common |
| Deshpande Samir | Chief Information Officer | 15 Dec 2023 | 334 | 10,079 (0%) | 0% | 0 | Humana Common | ||
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 171 | 3,493 (0%) | 0% | 463.6 | 79,272 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 310 | 8,975 (0%) | 0% | 0 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2023 | 351 | 9,711 (0%) | 0% | 0 | Humana Common | ||
| Broussard D. Bruce | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,184 | 2,184 | - | - | Restricted Stock Units | |
| Ventura Joseph C. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 373 | 4,560 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 309 | 8,805 (0%) | 0% | 0 | Humana Common | |
| Huval Timothy S. | Chief Administrative Officer | 15 Dec 2023 | 160 | 4,962 (0%) | 0% | 463.6 | 74,173 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2023 | 159 | 9,552 (0%) | 0% | 463.6 | 73,709 | Humana Common | |
| Deshpande Samir | Chief Information Officer | 15 Dec 2023 | 334 | 670 | - | - | Restricted Stock Units | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2023 | 351 | 0 | - | - | Restricted Stock Units | ||
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 310 | 621 | - | - | Restricted Stock Units | |
| Broussard D. Bruce | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,286 | 75,145 (0%) | 0% | 0 | Humana Common | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 36 | 223 (0%) | 0% | 463.6 | 16,689 | Humana Common |
| Samir Deshpande | Chief Information Officer | 15 Dec 2023 | 151 | 9,928 (0%) | 0% | 463.6 | 70,001 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 362 | 362 | - | - | Restricted Stock Units | |
| Diamond M. Susan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 588 | 4,354 (0%) | 0% | 0 | Humana Common | |
| C. Ventura Joseph | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 359 | 719 | - | - | Restricted Stock Units | |
| Huval Timothy S. | Chief Administrative Officer | 15 Dec 2023 | 406 | 4,774 (0%) | 0% | 0 | Humana Common | ||
| William Fleming Kevin | Chief Corporate Aff. Officer | 15 Dec 2023 | 147 | 7,987 (0%) | 0% | 463.6 | 68,146 | Humana Common | |
| C. Joseph Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 169 | 4,579 (0%) | 0% | 463.6 | 78,345 | Humana Common |
| Bruce Broussard D. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,465 | 0 | - | - | Restricted Stock Units | |
| Broussard Bruce D. | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,286 | 4,573 | - | - | Restricted Stock Units | |
| D. Bruce Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 2,184 | 73,719 (0%) | 0% | 0 | Humana Common | |
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 140 | 8,835 (0%) | 0% | 463.6 | 64,901 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 329 | 8,645 (0%) | 0% | 0 | Humana Common | |
| Deshpande Samir | Chief Information Officer | 15 Dec 2023 | 353 | 353 | - | - | Restricted Stock Units | ||
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 274 | 4,080 (0%) | 0% | 463.6 | 127,021 | Humana Common |
| Bruce Broussard D. | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 900 | 74,245 (0%) | 0% | 463.6 | 417,222 | Humana Common |
| George II Renaudin | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 142 | 1,547 (0%) | 0% | 463.6 | 65,828 | Humana Common |
| S. Huval Timothy | Chief Administrative Officer | 15 Dec 2023 | 343 | 5,122 (0%) | 0% | 0 | Humana Common | ||
| Renaudin George II | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 229 | 230 | - | - | Restricted Stock Units | |
| Kevin Fleming William | Chief Corporate Aff. Officer | 15 Dec 2023 | 390 | 0 | - | - | Restricted Stock Units | ||
| Renaudin George II | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 359 | 1,689 (0%) | 0% | 0 | Humana Common | |
| Diamond Susan M. | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 512 | 4,005 (0%) | 0% | 0 | Humana Common | |
| Renaudin George II | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 229 | 1,421 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 860 | 72,859 (0%) | 0% | 463.6 | 398,679 | Humana Common |
| S. Timothy Huval | Chief Administrative Officer | 15 Dec 2023 | 406 | 0 | - | - | Restricted Stock Units | ||
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 241 | 1,287 (0%) | 0% | 0 | Humana Common | |
| Huval S. Timothy | Chief Administrative Officer | 15 Dec 2023 | 168 | 4,779 (0%) | 0% | 463.6 | 77,881 | Humana Common | |
| Fleming Kevin William | Chief Corporate Aff. Officer | 15 Dec 2023 | 159 | 7,815 (0%) | 0% | 463.6 | 73,709 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 359 | 4,938 (0%) | 0% | 0 | Humana Common | |
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 149 | 8,496 (0%) | 0% | 463.6 | 69,073 | Humana Common |
| Sanjay Shetty K | President, CenterWell | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 308 | 616 | - | - | Restricted Stock Units | |
| William Kevin Fleming | Chief Corporate Aff. Officer | 15 Dec 2023 | 345 | 345 | - | - | Restricted Stock Units | ||
| Huval Timothy S. | Chief Administrative Officer | 15 Dec 2023 | 362 | 4,947 (0%) | 0% | 0 | Humana Common | ||
| Joseph Ventura C. | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 362 | 4,748 (0%) | 0% | 0 | Humana Common | |
| C. Ventura Joseph | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 463.58 per share. | 15 Dec 2023 | 168 | 4,770 (0%) | 0% | 463.6 | 77,881 | Humana Common |
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 329 | 0 | - | - | Restricted Stock Units | |
| M. Diamond Susan | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 588 | 1,176 | - | - | Restricted Stock Units | |
| C. Ventura Joseph | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 373 | 0 | - | - | Restricted Stock Units | |
| Agrawal Vishal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 309 | 309 | - | - | Restricted Stock Units | |
| W. John-Paul Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2023 | 114 | 259 (0%) | 0% | 0 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 06 Nov 2023 | 600 | 4,368 (0%) | 0% | 0 | Humana Common | ||
| Brad D. Smith | Director | 29 Sep 2023 | 59 | 191 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 181 | 12,605 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2023 | 33 | 101 | - | - | Restricted Stock Units | |
| Brad D. Smith | Director | 15 Sep 2023 | 386 | 386 (0%) | 0% | 0 | Humana Common | ||
| Brad D. Smith | Director | 15 Sep 2023 | 386 | 0 | - | - | Restricted Stock Units | ||
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 311 | 3,442 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 311 | 0 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 458.14 per share. | 01 Aug 2023 | 145 | 3,297 (0%) | 0% | 458.1 | 66,430 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 458.14 per share. | 01 Aug 2023 | 65 | 145 (0%) | 0% | 458.1 | 29,779 | Humana Common |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 210 | 421 | - | - | Restricted Stock Units | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2023 | 210 | 210 (0%) | 0% | 0 | Humana Common | |
| Brad D. Smith | Director | 30 Jun 2023 | 70 | 132 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 215 | 12,424 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 37 | 68 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 1,508 | 1,508 | - | - | Options | |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 May 2023 | 1,861 | 0 | - | - | Options | |
| Susan M. Diamond | Chief Financial Officer | Other type of transaction at price $ 0.00 per share. | 04 May 2023 | 700 | 3,131 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 04 May 2023 | 100 | 3,831 (0%) | 0% | 0 | Humana Common | |
| Susan M. Diamond | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 526.75 per share. | 04 May 2023 | 1,500 | 3,931 (0%) | 0% | 526.7 | 790,119 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 526.02 per share. | 04 May 2023 | 2,656 | 5,431 (0%) | 0% | 526.0 | 1,397,108 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 350.79 per share. | 04 May 2023 | 713 | 8,087 (0%) | 0% | 350.8 | 250,111 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 350.79 per share. | 04 May 2023 | 1,148 | 7,374 (0%) | 0% | 350.8 | 402,704 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 376.61 per share. | 04 May 2023 | 1,508 | 6,226 (0%) | 0% | 376.6 | 567,928 | Humana Common |
| Sanjay K Shetty | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 924 | 924 | - | - | Restricted Stock Units | |
| Sanjay K Shetty | President, CenterWell | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2023 | 3,964 | 3,964 | - | - | Options | |
| Brad D. Smith | Director | 31 Mar 2023 | 62 | 62 | - | - | Restricted Stock Units | ||
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 194 | 12,209 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 31 | 31 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Other type of transaction at price $ 0.00 per share. | 21 Mar 2023 | 3 | 151 | - | - | Phantom Stock Units | |
| David T. Feinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 441 | 441 (0%) | 0% | 0 | Humana Common | |
| David T. Feinberg | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 441 | 0 | - | - | Restricted Stock Units | |
| David A. Jones | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2023 | 10,000 | 32,440 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 28,494 | 98,534 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 10,919 | 87,615 (0%) | 0% | 510.2 | 5,571,338 | Humana Common |
| Bruce D. Broussard | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 505.85 per share. | 24 Feb 2023 | 17,575 | 70,040 (0%) | 0% | 505.8 | 8,890,233 | Humana Common |
| Bruce D. Broussard | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 26,484 | 26,484 | - | - | Options | |
| Bruce D. Broussard | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 6,859 | 6,859 | - | - | Restricted Stock Units | |
| Timothy S. Huval | Chief Administrative Officer | 24 Feb 2023 | 2,628 | 4,968 (0%) | 0% | 510.3 | 1,341,080 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 24 Feb 2023 | 1,678 | 7,596 (0%) | 0% | 510.2 | 856,187 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 24 Feb 2023 | 4,306 | 9,274 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 24 Feb 2023 | 3,973 | 3,973 | - | - | Options | ||
| Timothy S. Huval | Chief Administrative Officer | 24 Feb 2023 | 1,029 | 1,029 | - | - | Restricted Stock Units | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 24 Feb 2023 | 3,698 | 3,698 | - | - | Options | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 24 Feb 2023 | 958 | 958 | - | - | Restricted Stock Units | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 24 Feb 2023 | 4,560 | 6,829 (0%) | 0% | 0 | Humana Common | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 24 Feb 2023 | 1,802 | 5,027 (0%) | 0% | 510.2 | 919,457 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 24 Feb 2023 | 1,541 | 9,360 (0%) | 0% | 510.2 | 786,284 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 24 Feb 2023 | 3,878 | 3,878 | - | - | Options | ||
| Samir Deshpande | Chief Information Officer | 24 Feb 2023 | 1,004 | 1,004 | - | - | Restricted Stock Units | ||
| Samir Deshpande | Chief Information Officer | 24 Feb 2023 | 4,053 | 10,901 (0%) | 0% | 0 | Humana Common | ||
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 3,594 | 3,594 | - | - | Options | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 1,427 | 8,316 (0%) | 0% | 510.2 | 728,116 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 3,799 | 9,743 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 931 | 931 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 1,078 | 1,078 | - | - | Restricted Stock Units | |
| Joseph C. Ventura | Chief Legal Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 3,293 | 7,549 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 1,245 | 6,304 (0%) | 0% | 510.2 | 635,252 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 507.97 per share. | 24 Feb 2023 | 2,048 | 4,256 (0%) | 0% | 508.0 | 1,040,328 | Humana Common |
| Joseph C. Ventura | Chief Legal Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 24 Feb 2023 | 69 | 4,187 (0%) | 0% | 0 | Humana Common | |
| Joseph C. Ventura | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 4,162 | 4,162 | - | - | Options | |
| Susan M. Diamond | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 1,764 | 1,764 | - | - | Restricted Stock Units | |
| Susan M. Diamond | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 6,810 | 6,810 | - | - | Options | |
| Susan M. Diamond | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 1,125 | 4,718 (0%) | 0% | 510.2 | 574,023 | Humana Common |
| Susan M. Diamond | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 3,039 | 5,843 (0%) | 0% | 0 | Humana Common | |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 399 | 3,687 (0%) | 0% | 510.2 | 203,587 | Humana Common |
| Susan D. Schick | Seg Pres. Grp. & Military Bus. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 1,267 | 4,086 (0%) | 0% | 0 | Humana Common | |
| John-Paul W. Felter | SVP, Chief Accting Off & Cont. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 343 | 343 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 1,078 | 1,078 | - | - | Restricted Stock Units | |
| George II Renaudin | President, Medicare & Medicaid | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 24 Feb 2023 | 1,393 | 1,393 (0%) | 0% | 0 | Humana Common | |
| George II Renaudin | President, Medicare & Medicaid | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.24 per share. | 24 Feb 2023 | 347 | 1,046 (0%) | 0% | 510.2 | 177,054 | Humana Common |
| George II Renaudin | President, Medicare & Medicaid | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 4,162 | 4,162 | - | - | Options | |
| Brad D. Smith | Director | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | ||
| James J. O'Brien | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 1,794 (0%) | 0% | 0 | Humana Common | |
| David A. Jones | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 (0%) | 0% | 0 | Humana Common | |
| Frank A. D'Amelio | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | |
| David T. Feinberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | |
| Jorge S. Mesquita | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 1,603 (0%) | 0% | 0 | Humana Common | |
| John W. Garratt | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2023 | 380 | 380 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 185 | 12,015 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| Kurt J. Hilzinger | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 205 | 1,884 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| Karen W. Katz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 10 | 20 | - | - | Restricted Stock Units | |
| William J. Mcdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| William J. Mcdonald | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 180 | 1,866 | - | - | Restricted Stock Units | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| Marcy S. Klevorn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 2 | 2 | - | - | Restricted Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| Wayne A.I. Frederick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 4 | 6 | - | - | Restricted Stock Units | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 380 | 380 | - | - | Restricted Stock Units | |
| Raquel C. Bono | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 4 | 6 | - | - | Restricted Stock Units | |
| David A. Jones | Director | Sale of securities on an exchange or to another person at price $ 501.72 per share. | 21 Dec 2022 | 15,000 | 42,028 (0%) | 0% | 501.7 | 7,525,800 | Humana Common |
| David A. Jones | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Dec 2022 | 11,300 | 57,028 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,464 | 69,687 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,183 | 4,368 | - | - | Restricted Stock Units | |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,464 | 2,465 | - | - | Restricted Stock Units | |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,673 | 0 | - | - | Restricted Stock Units | |
| Bruce D. Broussard | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 860 | 70,040 (0%) | 0% | 510.0 | 438,617 | Humana Common |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,183 | 70,900 (0%) | 0% | 0 | Humana Common | |
| Bruce D. Broussard | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 970 | 68,717 (0%) | 0% | 510.0 | 494,719 | Humana Common |
| Bruce D. Broussard | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 1,052 | 67,223 (0%) | 0% | 510.0 | 536,541 | Humana Common |
| Bruce D. Broussard | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 2,673 | 68,275 (0%) | 0% | 0 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 404 | 0 | - | - | Restricted Stock Units | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 361 | 724 | - | - | Restricted Stock Units | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 404 | 5,372 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 635 | 4,968 (0%) | 0% | 497.7 | 316,045 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 165 | 5,603 (0%) | 0% | 510.0 | 84,153 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 361 | 5,768 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 185 | 5,407 (0%) | 0% | 510.0 | 94,354 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 405 | 5,592 (0%) | 0% | 0 | Humana Common | ||
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 185 | 5,187 (0%) | 0% | 510.0 | 94,354 | Humana Common | |
| Timothy S. Huval | Chief Administrative Officer | 15 Dec 2022 | 405 | 406 | - | - | Restricted Stock Units | ||
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 550 | 3,976 (0%) | 0% | 0 | Humana Common | |
| Timothy Alan Wheatley | Segment President, Retail | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 257 | 3,719 (0%) | 0% | 510.0 | 131,075 | Humana Common |
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 494 | 4,213 (0%) | 0% | 0 | Humana Common | |
| Timothy Alan Wheatley | Segment President, Retail | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 230 | 3,983 (0%) | 0% | 510.0 | 117,305 | Humana Common |
| Timothy Alan Wheatley | Segment President, Retail | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 266 | 3,426 (0%) | 0% | 510.0 | 135,665 | Humana Common |
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 570 | 3,692 (0%) | 0% | 0 | Humana Common | |
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 494 | 988 | - | - | Restricted Stock Units | |
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 550 | 550 | - | - | Restricted Stock Units | |
| Timothy Alan Wheatley | Segment President, Retail | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 570 | 0 | - | - | Restricted Stock Units | |
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 428 | 0 | - | - | Restricted Stock Units | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 389 | 390 | - | - | Restricted Stock Units | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 345 | 690 | - | - | Restricted Stock Units | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 428 | 2,070 (0%) | 0% | 0 | Humana Common | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 197 | 1,873 (0%) | 0% | 510.0 | 100,474 | Humana Common | |
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 389 | 2,262 (0%) | 0% | 0 | Humana Common | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 179 | 2,083 (0%) | 0% | 510.0 | 91,294 | Humana Common | |
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 345 | 2,428 (0%) | 0% | 0 | Humana Common | ||
| William Kevin Fleming | Seg Pres, Pharmacy Sol & CCAO | 15 Dec 2022 | 159 | 2,269 (0%) | 0% | 510.0 | 81,093 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 350 | 6,813 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 380 | 6,635 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 172 | 6,463 (0%) | 0% | 510.0 | 87,723 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 158 | 6,655 (0%) | 0% | 510.0 | 80,583 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 353 | 7,008 (0%) | 0% | 0 | Humana Common | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 160 | 6,848 (0%) | 0% | 510.0 | 81,603 | Humana Common | |
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 380 | 0 | - | - | Restricted Stock Units | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 350 | 351 | - | - | Restricted Stock Units | ||
| Samir Deshpande | Chief Information Officer | 15 Dec 2022 | 353 | 706 | - | - | Restricted Stock Units | ||
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 357 | 5,757 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 162 | 5,595 (0%) | 0% | 510.0 | 82,623 | Humana Common |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Dec 2022 | 329 | 5,924 (0%) | 0% | 0 | Humana Common | |
| Vishal Agrawal | Chief Strat & Corp Dev Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 510.02 per share. | 15 Dec 2022 | 149 | 5,775 (0%) | 0% | 510.0 | 75,993 | Humana Common |